LAURUS LABS

LAURUS LABS collaborates with the top ten generic pharmaceutical companies globally, selling APIs in 56 countries and regions. Its key research areas include antiretroviral, hepatitis C, and oncology drugs. LAURUS LABS has applied for 282 patents and owns 141 patents. Since its establishment, the company has commercialized more than 60 products across three different business units: Generics API, Generics FDF, and Synthesis.